Followers

November 09, 2023

US approves highly anticipated Eli Lilly weight loss drug

Administered by weekly injection, Zepbound has been indicated for patients who are obese or overweight patients with at least one weight-related condition, such as high blood pressure, type 2 diabetes or high cholesterol.


No comments:

Post a Comment